EDIT logo

EDITEditas Medicine Inc

$2.56
$0.17
(6.42%)
Today
Closed $2.48
$0.08
(3.23%)
Overnight
Updated: 09:29 PM EDT
EarningsAug 11
Mkt Cap$406.67M
Vol1.49M
News
all
press releases
Why Is Editas (EDIT) Down 12.4% Since Last Earnings Report?
Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
More News
News Placeholder
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026...
Yahoo! Finance: News
News Placeholder
Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 300 points with gains from Abercrombie & Fitch, Digital Turbine, Dycom Industries, Qfin Holdings, Editas Medicine, and others.read more...
Benzinga
News Placeholder
EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus
Editas narrows Q1 loss as costs fall, but revenues drop sharply. Pipeline focus shifts to in vivo gene editing and lead candidate EDIT-401.
Zacks
News Placeholder
Company News for May 6, 2026
Companies in The News Are: MPC,EDIT,BUD,AEP
Zacks
News Placeholder
Chardan Capital Boosts Editas Medicine (NASDAQ:EDIT) Price Target to $4.00
Chardan Capital boosted their price objective on Editas Medicine from $3.50 to $4.00 and gave the stock a 'buy' rating in a research report on Tuesday...
MarketBeat
News Placeholder
Editas Medicine (NASDAQ:EDIT) Announces Earnings Results
Editas Medicine (NASDAQ:EDIT - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.26) earnings per share (EPS) for the quarter, beating analysts' consensus...
MarketBeat
News Placeholder
Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates
Editas (EDIT) delivered earnings and revenue surprises of +11.86% and -67.07%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Editas Medicine (EDIT) to Release Quarterly Earnings on Monday
Editas Medicine (NASDAQ:EDIT) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at...
MarketBeat
News Placeholder
Editas Medicine (NASDAQ:EDIT) Rating Increased to Hold at Wall Street Zen
Wall Street Zen raised shares of Editas Medicine from a 'sell' rating to a 'hold' rating in a research note on Saturday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.